Evidence mapPaperPMID 36296534Full record

ArticleMolecules (Basel, Switzerland)2022

Investigation of the Chemical Composition, Antihyperglycemic and Antilipidemic Effects of

Abdulaziz K Al Mouslem, Hany Ezzat Khalil, Promise Madu Emeka, Ghallab Alotaibi

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Abdulaziz K Al MouslemDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0002-3868-2057
Hany Ezzat KhalilDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0001-7892-3380
Promise Madu EmekaDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.ORCID 0000-0003-1943-1874
Ghallab AlotaibiDepartment of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia.
King Faisal University · SAShaqra University · SA

Funding

Deanship of Scientific Research, King Faisal University Ra'ad Track (Grant No. 217001)
6 · The paper itself

Abstract

This study was designed to investigate the chemical profile, antihyperglycemic and antilipidemic effect of total methanolic extract (TME) of

Indexed as

Diabetes Mellitus, ExperimentalInsulinsAnimalsBlood GlucoseDiet, High-FatGlyburideHypoglycemic AgentsLipidsPlant ExtractsRatsStreptozocinUmbelliferonesBlood GlucoseGlyburideHypoglycemic AgentsInsulinsLipidsPlant ExtractsStreptozocinUmbelliferonesBassia eriophoradiabetes mellitushigh-fat dietSTZumbelliferone

Identifiers

PMID36296534
PMCPMC9611308
OpenAlexW4306399117

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.